Cocrystal Pharma, Inc.
COCP
$1.04
$0.032.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.73M | 4.77M | 6.92M | 9.86M | 13.02M |
| Total Receivables | 513.00K | 1.64M | 1.45M | 1.22M | 652.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 465.00K | 282.00K | 385.00K | 430.00K | 509.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 75.00K | 75.00K | 75.00K | 75.00K | 75.00K |
| Total Current Assets | 8.78M | 6.77M | 8.83M | 11.58M | 14.26M |
|
|
|||||
| Total Current Assets | 8.78M | 6.77M | 8.83M | 11.58M | 14.26M |
| Net Property, Plant & Equipment | 1.57M | 1.65M | 1.75M | 1.85M | 1.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 90.00K | 88.00K | 86.00K | 29.00K | 29.00K |
| Total Assets | 10.45M | 8.51M | 10.66M | 13.46M | 16.23M |
|
|
|||||
| Total Accounts Payable | 745.00K | 856.00K | 808.00K | 1.54M | 859.00K |
| Total Accrued Expenses | 449.00K | 658.00K | 814.00K | 585.00K | 796.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 326.00K | 317.00K | 309.00K | 301.00K | 293.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.52M | 1.83M | 1.93M | 2.43M | 1.95M |
|
|
|||||
| Total Current Liabilities | 1.52M | 1.83M | 1.93M | 2.43M | 1.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.26M | 1.34M | 1.42M | 1.51M | 1.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.78M | 3.17M | 3.36M | 3.93M | 3.53M |
|
|
|||||
| Common Stock & APIC | 347.49M | 343.11M | 343.02M | 342.94M | 342.86M |
| Retained Earnings | -339.82M | -337.77M | -335.72M | -333.42M | -330.15M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.67M | 5.33M | 7.30M | 9.52M | 12.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.67M | 5.33M | 7.30M | 9.52M | 12.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.67M | 5.33M | 7.30M | 9.52M | 12.70M |
|
|
|||||